Parimifasor
Parimifasor (LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
460.214
Molecular Formula
C18H11Cl2F4N5O
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1796641-10-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
